RELEXXII
- Product NDC
- 68025-088
- 11-digit product format
- 680250088
- Labeler code
- 68025
- Product ID
- 68025-088_86f477e9-07fc-466b-913e-1a4434c91df4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methylphenidate hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Vertical Pharmaceuticals, LLC
- Application
- NDA216117
- Marketing category
- NDA
- Marketing start
- 2022-06-23
- Substance
- METHYLPHENIDATE HYDROCHLORIDE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216117-001 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | |
| N216117-002 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | |
| N216117-003 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | |
| N216117-004 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | |
| N216117-005 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | |
| N216117-006 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 63MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | |
| N216117-007 | RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | 72MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-23 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N216117-001 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-001 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-001 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-001 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-001 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-002 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-002 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-002 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-002 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-002 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-003 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-003 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-003 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-003 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-003 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-004 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-004 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-004 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-004 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-004 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-005 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-005 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-005 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-005 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-005 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-006 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-006 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-006 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-006 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-006 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-007 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
| N216117-007 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-007 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | |
| N216117-007 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | |
| N216117-007 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N216117-001 | RELEXXII | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-002 | RELEXXII | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-003 | RELEXXII | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-004 | RELEXXII | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-005 | RELEXXII | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-006 | RELEXXII | 63MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-007 | RELEXXII | 72MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-001 | RELEXXII | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-002 | RELEXXII | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-003 | RELEXXII | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-004 | RELEXXII | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-005 | RELEXXII | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-006 | RELEXXII | 63MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-007 | RELEXXII | 72MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-001 | RELEXXII | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-002 | RELEXXII | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-003 | RELEXXII | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-004 | RELEXXII | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-005 | RELEXXII | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-006 | RELEXXII | 63MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216117-007 | RELEXXII | 72MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-001 | RELEXXII | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-002 | RELEXXII | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-003 | RELEXXII | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-004 | RELEXXII | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-005 | RELEXXII | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-006 | RELEXXII | 63MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216117-007 | RELEXXII | 72MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-001 | RELEXXII | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-002 | RELEXXII | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-003 | RELEXXII | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-004 | RELEXXII | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-005 | RELEXXII | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-006 | RELEXXII | 63MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216117-007 | RELEXXII | 72MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2022-06-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216117-001 | RELEXXII | 18MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216117-002 | RELEXXII | 27MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216117-003 | RELEXXII | 36MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216117-004 | RELEXXII | 45MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216117-005 | RELEXXII | 54MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2022-06-23 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N216117-001 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-001 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-001 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-001 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-001 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-002 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-002 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-002 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-002 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-002 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-003 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-003 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-003 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-003 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-003 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-004 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-004 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-004 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-004 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-004 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-005 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-005 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-005 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-005 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-005 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-006 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-006 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-006 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-006 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-006 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-007 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-007 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-007 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-007 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216117-007 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-001 | 10265308 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-001 | 10695336 | 2037-02-03 | U-4032 | 2024-11-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-001 | 9707217 | 2037-02-03 | Drug product | 2024-11-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-001 | 9827234 | 2037-02-03 | U-4032 | 2024-11-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216117-001 | 9855258 | 2037-02-03 | U-4032 | Drug product | 2024-11-18 | 31067a03dcf5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RELEXXII
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METHYLPHENIDATE HYDROCHLORIDE | 45 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4B3SC438HI | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1091155 | Internal RxNorm lookup |
| 1091170 | Internal RxNorm lookup |
| 1091185 | Internal RxNorm lookup |
| 1091210 | Internal RxNorm lookup |
| 1995461 | Internal RxNorm lookup |
| 2052826 | Internal RxNorm lookup |
| 2605796 | Internal RxNorm lookup |
| 2605798 | Internal RxNorm lookup |
| 2605943 | Internal RxNorm lookup |
| 2605946 | Internal RxNorm lookup |
| 2668496 | Internal RxNorm lookup |
| 2668499 | Internal RxNorm lookup |
| 2668502 | Internal RxNorm lookup |
| 2668505 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68025-088-30 | RELEXXII | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68025-088-30 | EA - Each | 68025-088 | 3b2ed09c-141d-4344-9221-b475cb2f8c89 | 1 | 2022-12-07 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | Vertical Pharmaceuticals, LLC | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 216117 NDA216117 68025-088 |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Trigen Laboratories, LLC | dd8d7b6e-c23d-4e16-bb53-959e9127ebc6 | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 216117 NDA216117 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1091155 | methylphenidate HCl 18 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091170 | methylphenidate HCl 27 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091185 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091210 | methylphenidate HCl 54 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1995461 | methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668496 | RELEXXII 18 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668499 | RELEXXII 27 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668502 | RELEXXII 36 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668505 | RELEXXII 54 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2052826 | RELEXXII 72 MG 24HR Extended Release Oral Tablet | PSN | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668496 | 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668499 | 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668502 | 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605943 | 24 HR methylphenidate hydrochloride 45 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668505 | 24 HR methylphenidate hydrochloride 54 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605946 | 24 HR methylphenidate hydrochloride 63 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2052826 | 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet [Relexxii] | SBD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091155 | 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091170 | 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091185 | 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605798 | 24 HR methylphenidate hydrochloride 45 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091210 | 24 HR methylphenidate hydrochloride 54 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605796 | 24 HR methylphenidate hydrochloride 63 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1995461 | 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet | SCD | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668496 | 24 HR Relexxii 18 MG Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668499 | 24 HR Relexxii 27 MG Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668502 | 24 HR Relexxii 36 MG Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668505 | 24 HR Relexxii 54 MG Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2052826 | 24 HR Relexxii 72 MG Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091155 | methylphenidate hydrochloride 18 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091170 | methylphenidate hydrochloride 27 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091185 | methylphenidate hydrochloride 36 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605798 | methylphenidate hydrochloride 45 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1091210 | methylphenidate hydrochloride 54 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605796 | methylphenidate hydrochloride 63 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 1995461 | methylphenidate hydrochloride 72 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668496 | Relexxii 18 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668499 | Relexxii 27 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668502 | Relexxii 36 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605943 | Relexxii 45 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2668505 | Relexxii 54 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2605946 | Relexxii 63 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
| 2052826 | Relexxii 72 MG 24 HR Extended Release Oral Tablet | SY | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 18 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68025-088-10 | 68025008810 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-088-10) | 2022-06-23 | 0000-00-00 | No | No | Current |
| 68025-088-30 | 68025008830 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-088-30) | 2022-06-23 | 0000-00-00 | No | No | Current |